Episode 22: Endometriosis and Cancer Risk

This academic review examines the epidemiological and molecular link between endometriosis and an elevated risk of specific ovarian cancer subtypes, namely clear cell and endometrioid carcinomas. While research indicates a statistically significant increase in relative risk, the authors emphasize that the absolute lifetime risk for most women remains very low, typically under five percent. The text details how chronic inflammation, oxidative stress, and shared genetic mutations like ARID1A create a biological continuum between benign lesions and malignant transformation. Despite these connections, the expert panel concludes that routine oncologic surveillance or prophylactic surgery is currently unjustified for endometriosis patients. Ultimately, the source advocates for individualized risk assessment and clearer patient counseling to balance medical awareness with the avoidance of unnecessary anxiety.